Amgen

Eli Lilly, Amgen join forces to scale production of COVID-19 antibody cocktails
Eli Lilly, Amgen join forces to scale production of COVID-19 antibody cocktails
Fierce Pharma
Eli Lilly
Amgen
LY-CoV-55
antibody cocktail
COVID-19
Flag link:
ESC: Amgen chases pediatric use for cholesterol-busting PCSK9 med Repatha
ESC: Amgen chases pediatric use for cholesterol-busting PCSK9 med Repatha
Fierce Pharma
ESC
Amgen
Repatha
Sanofi
Regeneron
Praluent
cholesterol
Flag link:
A new biotech forms to revive Amgen's old heart drug
A new biotech forms to revive Amgen's old heart drug
BioPharma Dive
Amgen
NewAmsterdam Pharma
obicetrapib
heart disease
Flag link:
AbbVie's Skyrizi stands to gain as docs move away from older psoriasis meds—Amgen's Otezla included
AbbVie's Skyrizi stands to gain as docs move away from older psoriasis meds—Amgen's Otezla included
Fierce Pharma
psoriasis
AbbVie
Skyrizi
Amgen
Celgene
Otezla
Flag link:
Amgen-partnered researchers treat diabetes in mice by silencing IL-2's inflammatory power
Amgen-partnered researchers treat diabetes in mice by silencing IL-2's inflammatory power
Fierce Biotech
Amgen
Flag link:
Teva's Ajovy, chasing Amgen and Lilly drugs, gains steam after autoinjector rollout
Teva's Ajovy, chasing Amgen and Lilly drugs, gains steam after autoinjector rollout
Fierce Pharma
Teva Pharmaceutical
migraines
Ajovy
autoinjectors
Amgen
Eli Lilly
Flag link:
Platform study designed to rapidly screen potential Covid-19 drugs enrolls first patients
Platform study designed to rapidly screen potential Covid-19 drugs enrolls first patients
MedCity News
COVID-19
Amgen
AbbVie
Takeda
patients
clinical trials
Flag link:
Amgen's psoriasis pill Otezla thrives amid pandemic against injectable rivals
Amgen's psoriasis pill Otezla thrives amid pandemic against injectable rivals
Fierce Pharma
Otzela
Celgene
Amgen
psoriasis
COVID-19
Flag link:
Amgen tosses back unwanted bispecific to Xencor as KRAS data on track for 2020 readout
Amgen tosses back unwanted bispecific to Xencor as KRAS data on track for 2020 readout
Fierce Biotech
Amgen
bispecific antibodies
Xencor
Flag link:
Amgen (AMGN) Tops Q2 Earnings and Revenue Estimates
Amgen (AMGN) Tops Q2 Earnings and Revenue Estimates
Yahoo/Zacks.com
Amgen
earnings
Flag link:
Chinese Biotech Beigene to Raise $2.1 Billion in Share Sale
Chinese Biotech Beigene to Raise $2.1 Billion in Share Sale
Bloomberg
China
BeiGene
Amgen
NASDAQ
Flag link:
Could Amgen test Enbrel or other anti-TNF drugs against COVID-19? CEO Bradway drops a hint
Could Amgen test Enbrel or other anti-TNF drugs against COVID-19? CEO Bradway drops a hint
Fierce Pharma
Amgen
clinical trials
COVID-19
anti-TNF
Enbrel
Bob Bradway
Pharma CEOs
Flag link:
Merck, Lilly and Amgen win again in lawsuit over drug prices in TV ads. Will it stick?
Merck, Lilly and Amgen win again in lawsuit over drug prices in TV ads. Will it stick?
Fierce Pharma
television ads
DTC ads
Merck
Eli Lilly
Amgen
drug pricing
Flag link:
Lilly touts Emgality's ability to reduce migraine patients' overall pain in first look at 'holistic approach'
Lilly touts Emgality's ability to reduce migraine patients' overall pain in first look at 'holistic approach'
Fierce Pharma
Eli Lilly
migraines
Amgen
Teva Pharmaceutical
Lundbeck
Emgality
Flag link:
Astellas' Anemia Drug Roxadustat Shows Non-Inferiority to Amgen's Aranesp
Astellas' Anemia Drug Roxadustat Shows Non-Inferiority to Amgen's Aranesp
BioSpace
Astellas
clinical trials
roxadustat
Amgen
Aranesp
anemia
chronic kidney disease
Flag link:
ASCO 2020 round-up: Virtual conference still delivers the drama ASCO 2020 round-up: Virtual conference still delivers the drama
ASCO 2020 round-up: Virtual conference still delivers the drama ASCO 2020 round-up: Virtual conference still delivers the drama
Pharmaforum
ASCO 2020
Amgen
AstraZeneca
Bristol-Myers Squibb
cancer
CAR-T
COVID-19
Keytruda
Kyprolis
Tagrisso
Flag link:
ASCO data for Amgen’s acute leukemia drug disappoint, but path forward remains, experts say
ASCO data for Amgen’s acute leukemia drug disappoint, but path forward remains, experts say
MedCity News
ASCO 2020
Amgen
AMG 330
acute myeloid leukemia
Flag link:
ASCO: Amgen's KRAS drug shows 'modest' efficacy beyond NSCLC
ASCO: Amgen's KRAS drug shows 'modest' efficacy beyond NSCLC
Fierce Biotech
Amgen
AMG-510
colorectal cancer
ASCO 2020
Flag link:
Amgen-backed QurAlis Snags $42 Million in Series A to Develop ALS Treatments
Amgen-backed QurAlis Snags $42 Million in Series A to Develop ALS Treatments
BioSpace
Amgen
QurAlis
ALS
Flag link:
Sanofi takes aim at J&J's myeloma star Darzalex with latest Sarclisa trial win
Sanofi takes aim at J&J's myeloma star Darzalex with latest Sarclisa trial win
Fierce Pharma
Sanofi
Sarclisa
Multiple Myeloma
Amgen
Kyprolis
Flag link:

Pages